| Active substance |
Albendazole, Ivermectin |
| Also known as |
Albendazolum |
| Blood pressure |
No significant effect |
| Chemical name |
Methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate |
| Dosage (medical) |
400 mg as a single dose or in two divided doses for adults and children over 2 years of age |
| Dosage (sports) |
Not applicable |
| Effects |
Effective against a broad range of worms, and used in the treatment of hydatid disease and neurocysticercosis |
| Formula |
C12H15N3O2S |
| Half-life |
8-12 hours |
| Hepatotoxicity |
Rare, but potential risk with prolonged usage |
| Lab Test |
Liver function tests recommended during prolonged therapy |
| Main action |
Antihelmintic |
| Side effects |
Stomach pain, nausea, vomiting, headache, dizziness, hair loss |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
6/400mg |
| Substance class |
Benzimidazole derivative |
| Trade name |
Albenza, Zentel |
| Use in sports |
None |
| Water Retention |
No |
| Manufacturer |
Mankind Pharma Ltd. |
| Packing |
1 tab/blister |
